Business Context and Reporting Period
This Form 8-K was filed by Digital Ally, Inc. (trading symbol: DGLY) on January 15, 2021, reporting events that occurred on January 14, 2021. The filing details the closing of a registered direct offering of equity securities.
Key Financial Metrics and Transaction Details
The Company closed a registered direct offering with two investors, resulting in the following capital structure changes and proceeds:
- Gross Proceeds: Approximately $30,950,000 (before deducting discounts, commissions, and offering expenses).
- Common Stock Issued: 2,800,000 shares at a par value of $0.001 per share.
- Pre-Funded Warrants: Issued to purchase up to 7,200,000 shares at an exercise price of $0.01 per share (subject to beneficial ownership limitations).
- Common Stock Purchase Warrants: Issued to purchase up to 10,000,000 shares at an initial exercise price of $3.25 per share, exercisable for five years.
- Placement Agent: Kingswood Capital Markets, division of Benchmark Investments, Inc.
Note: This filing does not provide specific data on revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes
The primary material change is the significant increase in outstanding share count and potential dilution resulting from the issuance of 2,800,000 common shares, 7,200,000 pre-funded warrant shares, and 10,000,000 warrant shares. The filing does not provide comparative financial data against prior periods.
Use of Proceeds and Management Commentary
Management intends to use the net proceeds from the offering for:
- Working capital.
- Product development.
- Order fulfillment.
- General corporate purposes.
- Potential acquisition of businesses, products, technologies, or licenses complementary to the Company's business.
The filing does not contain specific forward-looking guidance, risk factors beyond standard offering terms, or discussion of unusual items.
Investor Verification Checklist
- Verify the final net proceeds after deducting placement agent fees and offering expenses.
- Confirm the total number of outstanding shares post-offering to assess dilution impact.
- Review the specific terms of the warrants, including anti-dilution adjustments and exercise conditions.
- Monitor future filings for details on the deployment of capital into acquisitions or product development.